New modalities of transdermal testosterone replacement

Shehzad Basaria, Adrian S. Dobs

Research output: Contribution to journalReview article

Abstract

Hypogonadism, irrespective of its etiology, has a negative impact on various physiologic parameters. These parameters may improve with testosterone replacement therapy. Before 1990, intramuscular testosterone esters were the principal modality of testosterone replacement in men with hypogonadism. Although effective, they have a non-physiologic pharmacokinetic profile. Recently, transdelmal preparations of testosterone have become widely available. These include a scrotal patch, non-scrotal patches and, the most recent development, a gel. Several studies have shown that transdermal testosterone replacement is physiologic, efficacious and has a good safety profile. Transdermal testosterone replacement improves bone mass and lean body mass, decreases fat mass, and improves mood and sexual function. There are no harmful effects on the prostate and lipids. Acne, polycythemia and gynecomastia are less common with this form of therapy than with the intramuscular esters.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalTreatments in Endocrinology
Volume2
Issue number1
DOIs
StatePublished - Sep 9 2003

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'New modalities of transdermal testosterone replacement'. Together they form a unique fingerprint.

  • Cite this